Dibenzazepine derivatives and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10125113
APP PUB NO 20170283392A1
SERIAL NO

15623120

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides dibenzazepine derivatives having Formula I or I(A):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PURDUE PHARMA L PONE STAMFORD FORUM 201 TRESSER BOULEVARD STAMFORD CT 06901-3431

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lynch, Stephen M Westfield, US 20 105
Tafesse, Laykea Robbinsville, US 106 1585

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 13, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 13, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00